ABSTRACT
Antitumor monoclonal antibodies have shown clinical promise as cancer cell surface
targeting agents. The aims of this study was to evaluate the conformational study of the
some cell surface targeting peptide which can be used in multiple myeloma treatment. The
conformational structure of the 6-mer peptide of YIHYIF in different forms has been
investigated by the PCILO method. The computational results revealed that the peptide
which blocked it’s C-terminal and with free N-terminal has better functionality group for
bind to M- protein. Thus conformational studies shown that H3N+-YIHYIF-NHMe can be
used as cancer cell surface targeting peptide in multiple myeloma.